Membrane and cytoplasmic fractions of Mycoplasma hominis inhibited the multiplication of this mycoplasma. Arginine deiminase (EC 3.5.3.6), isolated from both fractions, reproduced the inhibition. The purified cytoplasmic deiminase had a subunit M , of 49000, a specific activity of 53 units (mg protein)-' and an A280/A260 ratio of 1.76. The membrane-associated enzyme had an identical M , but lower values for specific activity [39 units (mg protein)-'] and the A280/A260 ratio (1 -46). In experiments in vitro, recent clinical isolates of M . hominis produced less arginine deiminase, but grew faster than the laboratory reference strain PG 21. In addition, other growth inhibitory components associated with membrane preparations were detected in recent clinical isolates but were absent from strain PG 21.
Arginine deiminase activity was assayed by the method of Archibald as modified by Ratner (1955) ; one unit of enzyme activity was defined as the formation of 1 pmol citrulline min-l at 37 "C. Whole cells were disrupted by freeze-thawing five times before the determination.
Preparations of cytoplasmic and membrane fractions. Overnight cultures in Edward's broth (pH 74-7.2) were harvested by centrifuging at lOOOOg for 30 min. They were then washed twice at 5°C with sterile 0.25 M-NaC1, suspended in 0.25 M-NaCl, concentrated to 1/100 the volume of the original culture, and disrupted by sonication as described by Weickman & Fahrney (1977) . Concentrated cell preparations were streaked on blood agar plates which were incubated at 37 "C to detect bacterial contamination. Membranes were collected by centrifuging at 45000g for 45 min. They were then washed consecutively with deionized water, 0.05 M-NaCl in 0.01 M-phosphatebuffered saline (PBS), pH 7.2, and deionized water (Razin & Rottem, 1976) . The original supernatants, further centrifuged at 180000g for 1 h, were considered as cytoplasmic fractions. They were concentrated with an Amicon concentrator (B15) to 10 mg protein ml-l, if necessary. Both preparations were stored at -70 "C.
PuriJication ofarginine deiminase. The enzymes were isolated from cytoplasmic fractions (10 mg protein ml-l) by protamine sulphate fractionation (1 mg ml-l; Weickman & Fahrney, 1977) . Supernatant from the fractionation (2-3 ml) was applied directly to an Ultrogel column (1.6 x 87 cm, AcA 44, LKB), and was eluted with 0.01 M-PBS, pH 7.2 (flow rate 2-3 ml h-l). Azgo and precipitin reactions to antiserum PG21 (immunodiffusion plate, pattern B, Hyland) and determined for each 2 ml fraction. Protein and arginine deiminase activity were determined from A280 peak fractions and/or those showing precipitin reactions.
Active fractions were combined, concentrated with Amicon B 15 concentrators to 1-2 ml, rechromatographed on the same column and eluted with 0.025 M-Tris/HCl buRer, pH 9.0. If the specific activities of the enzyme fractions were more than 50 units (mg protein)-', they were considered to be pure (Weickmann et al., 1978) and were stored at -70 "C.
To extract enzymes from membrane preparations, Tween 20 was added to the preparations (4-5 mg protein ml-I) in 0*02M-Tris/HC1 buffer, pH9.0; the preparations were then shaken at room temperature for 2 h and centrifuged at 180000g for 2 h (Johansson et af., 1975) . The supernatant (1 ml) was then chromatographed, firstly on an Ultrogel AcA 34 column (1 x 53 cm) with PBS (pH 7.2) to remove the detergent, and then on an Ultrogel AcA 44 column with Tris/HCl buffer, pH 9.0, to purify enzymes.
Homogeneity of the purified enzymes was ascertained by immunoelectrophoresis and gel electrophoresis. Disc polyacrylamide gel electrophoresis was done in the presence of 1 % SDS (Fairbanks et al., 1971 ). The M , of purified enzymes was estimated with a reference kit (Pharmacia), which contained the following standards: thyroglobulin ( M , 669000), ferritin (440000), catalase (232000), lactate dehydrogenase (140000) and albumin (67000). Immunoelectrophoresis (LKB kit) was done with the purified enzyme against the homologous and heterologous antisera prepared against whole cells.
Growth inhibition. Twofold serial dilutions of material with deiminase activity (0.05 ml) were made in Hayflick's medium in the microtitre system (Falcon) and, unless otherwise stated, 10-100 CCUs0% of the mycoplasmas in 0.15 ml of the medium were added to each well. Plates were sealed and incubated at 37 "C. The highest dilution which prevented the pH changes of the medium after 5 d was considered as containing 1 growth inhibition (GI) unit (Lin & Kass, 1975) .
R E S U L T S
Growth and production of arginine deiminase In modified Edward's medium, there were differences in growth and enzyme production between strain PG 21 and the other six strains, as represented by strain 93 (Table 1) . Early exponential phase growth was reached at pH 7-0-7.2, and it took more than 24 h for strain PG 21 to reach that phase compared to < 20 h for strain 93. Strain PG 21 produced 2-5 times more enzyme with a constant rate of production. On the other hand, the rate of enzyme production for strain 93 increased gradually from early to late exponential phase as reflected in increasing specific activities.
Approximately 45% of the cellular proteins and 95 % of the deiminase activity were recovered in the cytoplasmic fraction. Although membrane preparations consistently showed low deiminase activity (Table l) , there were again differences between strains PG21 and 93. Membrane preparations from strain PG 21 had 2-3 times more deiminase activity, but lower GI activity, than those from strain 93. When the GI activities were compared with the deiminase activities, it was found that strain PG 21 had 30-50 GI units (deiminase unit)-' whereas strain 93 had 300-500 GI units (deiminase unit)-'. No such differences were observed for cytoplasmic fractions ( Table 2) . As shown below, purified membrane enzymes from both strains had the same values for GI units (deiminase unit)-l , indicating the presence of additional growthinhibitory components in strain 93. Initial isolates of two reference strains (93 and 132) stored at -70 "C were recovered and tested. When cells were harvested in exponential phase (pH 7-0-7.2), the patterns of production of arginine deiminase and GI activities in the membrane and cytoplasmic fractions were similar to those of the recent clinical isolates, within the ranges indicated above (Tables 1 and 2 ).
Cytoplasmic enzyme
Purification of arginine deiminase from the cytoplasmic fraction of strains PG 21 and 93 is summarized in Fig. 1 and Table 3 . The specific activities of the purified enzymes were 55 and 51 units (mg protein)-* respectively, representing 5-to 13-fold increases in the activity. It should be noted that the values for GI units (deiminase unit)-' of the preparations remained almost constant, between 32 and 42, after each step of the purification procedure.
Purified enzymes showed (1) one major polypeptide band in polyacrylamide gel electro- Membrane-associated deiminase When washed membranes were extracted with Tween 20, all the deiminase activity was recovered in the Tween 20 fractions. Approximately 45% and 25% of the membrane proteins were solubilized from strains PG 21 and 93 respectively. Deiminase purified from membranes of strains PG 21 and 93 had an RF of 0.6 (Fig. 2) G ro w t h in h ib it ion GI values of purified enzyme preparations were inversely related to the concentrations of mycoplasmal cells being tested; 0.5 units of deiminase inhibited 6 CCU,,, of the mycoplasma (Table 4) Final culture pH shown in parentheses.
remained viable in the growth medium for at least 2 d but failed to multiply in the presence of enzyme preparations ( Table 5 ). The pH of the inhibited culture remained low (< 8.0), suggesting that arginine was not depleted but that the metabolism of arginine was inhibited in the medium.
DISCUSSION
Prokaryotes metabolize arginine by the arginine dihydrolase pathway (Razin, 1978 Arginine-utilizing strains of mycoplasmas are particularly toxic to mammalian cells in culture. Soluble extracts of these mycoplasmas inhibit lymphocyte mitosis, antibody production and the multiplication of mammalian cells in culture ; partially purified arginine deiminases from mycoplasmas, bacteria and yeasts reproduce these effects (Simberkoff et al., 1969; Gill & Pan, 1970) . Large amounts of the arginine dihydrolase pathway enzymes were present in a laboratory reference strain of murine mycoplasma, M . arthritidis, grown in an artificial medium, and arginine deiminase constitutes about 10% of the cytoplasmic proteins (Schimke et al., 1966; Weickmann et al., 1978) . The results reported here for the laboratory reference strain PG 21 of the human genital mycoplasma, M . hominis, are similar. In addition, membrane-associated arginine deiminase has been detected and isolated from this strain. However, recent or original clinical isolates of M . horninis have been shown to contain less of the enzymes than the laboratory reference strain. The presence of cytoplasmic and membrane-associated arginine deiminases in M . hominis suggests multiple metabolic roles for arginine in the non-glycolytic, arginine-utilizing mycoplasmas. It has been suggested that the arginine dihydrolase pathway is a major source of energy, but recent results suggest that arginine is used in M . hominis as an alternative energy source (Fenske & Kenny, 1976) . On the other hand, the pathway might be required for active 5 compared to 1.8) . The results presented here show that the cytoplasmic arginine deiminase from M . horninis resembles deiminase I in physical properties and that the membrane-associated enzyme resembles deiminase 11. The membrane-associated deiminase appears to be a peripheral protein since it can be extracted by Tween 20. Unfortunately, Weickmann et al. (1978) did not determine deiminase activity in the membrane, so more direct comparison with the present work to determine the intracellular localization of deiminase I1 is not possible.
In the experimental conditions reported here, the minimum amount of mycoplasma arginine deiminase required to inhibit the multiplication of M . horninis was 0-03-0.06 units ml-l ( 1969; Gill & Pan, 1970) . Thus, it appears that cells requiring arginine for growth are susceptible to the inhibitory effects of arginine deiminases from various sources. The possibility exists that release of the enzyme in vivo may play a role in the pathogenesis of diseases caused by M . horninis. On the other hand, some potent growth-inhibiting components are associated with membranes of recent clinical isolates but absent from the laboratory reference strain PG 21. Further studies are needed to identify these components and to determine whether they play a role in pathogenesis.
Recent clinical isolates of M . horninis produced less arginine deiminase, in both membranes and cytoplasm, but grew faster than the laboratory reference strain PG21 under the experimental conditions used. The finding of growth inhibitory components other than the deiminase in membranes of recent clinical isolates but not in strain PG 21, and previous results showing that strain PG 21, among the seven reference strains of M . horninis examined, had the fewest antigens expressed at the cell surface (Lin, 1980) , indicate that recent clinical isolates of M . horninis are biochemically different from laboratory-adapted strains and that losses of 'virulence' factors may occur during laboratory passages.
Understanding the mechanism of growth inhibition may help to define the metabolic and pathogenic role of arginine deiminase. Preliminary results suggest that attachment of arginine deiminases to mycoplasma cells may inhibit the metabolism of arginine and, concurrently, multiplication of the mycoplasma, since live mycoplasma cells or membrane preparations in non-growth media absorbed deiminase and the corresponding growth inhibiting activities from the cytoplasmic fractions. It is also possible that reactive sites for deiminase and growth inhibition may be different. An antiserum to the purified cytoplasmic enzyme of strain PG 21 has been prepared; at a 1 :4 dilution this antiserum neutralized >90% of the cytoplasmic arginine deiminase (2 units) and growth inhibiting (128 GI units) activities of strain PG 21. It also neutralized 70% of the deiminase activity (1 unit) in membranes but failed to affect growth inhibiting activity (64 units). Further studies are needed to understand the mechanism of growth inhibition. Preparations of monoclonal antibodies to the enzyme may help to define the mechanisms involved in growth inhibition. 
